Category Specific RSS

Categories: News

Stockland of plenty – Property giant reports strong results against market forces

Despite a construction industry crisis that affects several sectors that property company Stockland (ASX: SGP) operates in, the diversified project builder has announced a bumper FY22 result underpinned by $1.38 billion in statutory profit. 

For the full year ended 30 June 2022, Stockland’s $1.38 billion profit represented a 25% increase on FY21. Funds From Operations (FFO) came in at $851 million, up 8% higher on FY21. While also reporting Net Tangible Assets at $4.31 per share, gaining 8.3% YoY, reflecting solid gains from a high-quality real estate portfolio. These results allowed the Company to declare a total distribution of 26.6c per share.

“We delivered a strong operational and financial result for FY22, slightly above our guidance range for FFO per security, in another year of significant market disruption,” said Managing Director and CEO, Turan Gupta. 

In February 2022, Stockland announced two new significant capital partnerships. One of the partnerships was Stockland Residential Rental Partnership with Mitsubishi Estate Asia, where Stockland was to develop and own land lease communities with the plan to deliver over $4 billion in development costs. The aim of the partnership was to generate new, high-quality recurring management and rental income from their substantial land bank portfolio.

The other partnership announced is with Ivanhoe Cambridge, where they planned to develop and construct a Life Sciences and Technology Precinct at M_Park corporate campus located in Macquarie Park, NSW. With an expected end value of over $2 billion, Stockland will construct three commercial buildings with the capacity to house over 13,000 workers, scheduled for completion by the end of FY24. 

Stockland’s commercial properties net valuations increased 7.3% to $725 million. However, the valuation change over the past 12 months wasn’t equal across all of Stockland’s divisions. Its Logistics commercial property increased 15.9% to $391 million, compared to Workplace and Town Centres commercial properties which only increased 1.9% to $37 million and 5.4% to $297 million, respectively. These revaluation outcomes reflect a strong performance across its portfolio, but also reflects the growth in the market rental space that investors and analysts have seen throughout the previous year. 

For each of the divisions, rent collection remained very strong where the Company collected over 99% of gross rent for FY22. Even when accounting for COVID-19 abatements, these figures are significant as the majority of office buildings and shopping centres have struggled to collect rent due to the current economic environment. With rent collection remaining fairly high, this signifies the reliability of the Company’s portfolio and it positions the Company to reinvest for future projects. 

Jack Cornips

Trading Desk Assistant at Emerald Financial

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

7 days ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

2 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

2 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

3 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

4 weeks ago